BLOOD BANKING AND BLOOD PRODUCTS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Blood Banking and Blood Products in US$ Million by the following Product Segments: Blood Components and Plasma Products (Whole Blood & Cellular Components, & Plasma Fractions), and Equipment, Blood Tests and Other Consumables (Includes blood screening and related QC function, but excludes patient diagnosis). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain. The report profiles 232 companies including many key and niche players such as -

AABB
America’s Blood Centers
American Red Cross
Canadian Blood Services
Japan Red Cross Society


Click here to request a full list of companies covered in the report...

Code : MCP-1028
Price : $4950
Companies : 232
Pages : 1025
Date : February 2013
Market Data Tables : 275

Complimentary Market Brief:


Request a Complimentary Copy of the Report Insights, Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Healthcare Scares Propel the Market.....II-1
Blood Transfusion Worldwide: A Kaleidoscope of Stark Contrasts.....II-1
1$100
   Worldwide Blood Banking and Blood Products Market at a Glance (All figures are 2012
  estimates & CAGR is for the period 2010-2018).....II-2
Current and Future Analysis.....II-2
Analysis by Geographic Region.....II-2
1$100
   Analysis by Product Segment.....II-3
World Blood Components and Plasma Market Analysis in Units.....II-3
1$100
   Table 1: World Recent Past, Current & Future Analysis for Blood Components and Plasma by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-41$350
   Table 2: World 9-Year Perspective for Blood Components and Plasma by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2010, 2012 & 2018 (includes corresponding Graph/Chart).....II-51$350
   Red Blood Cells – A Key Blood Component and a Major Contributor.....II-6
Table 3: World Recent Past, Current & Future Analysis for Red Blood Cells by Region/Country - US, Europe, Japan, and Rest of World Markets Independently Analyzed with Annual Consumption in Million Units for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-6
1$350
   Table 4: World 9-Year Perspective for Red Blood Cells by Region/Country - Percentage Breakdown of Volume Consumption for US, Europe, Japan, and Rest of World Markets for Years 2010, 2012 & 2018 (includes corresponding Graph/Chart).....II-7
Blood Plasma Derivatives: An Overview.....II-7
Blood Plasma Sourcing.....II-7
1$350
   Plasma Derived Products: Production.....II-8
IVIG.....II-8
Factor VIII.....II-8
Albumin.....II-8
Costs Associated with Plasma Derivatives Production.....II-8
1$100
   Table 5: Global Plasma Derivatives Market: Percentage Breakdown of Costs Associated with Production (includes corresponding Graph/Chart).....II-9
Player Scenario.....II-9
Table 6: Global Plasma Derived Products Market (2011): Percentage Share Breakdown by Leading Players - Baxter, CSL, Grifols (incl. Talecris), Octapharma, LFB, Biotest, Kedrion and Others (includes corresponding Graph/Chart).....II-9
1$350
   Table 7: Global IVIg Market (2011): Percentage Breakdown of Market Share for Leading Players (includes corresponding Graph/Chart).....II-10
Indications Addressed by Major Global IVIg Manufacturers.....II-10
Table 8: Comparative Costs between Plasma Protein Therapies and Artificially Synthesized Pharmaceuticals (includes corresponding Graph/Chart).....II-10
1$350
   Table 9: Global Plasma Market in the Recent Past (2008): Market Shares of CSL Behring and Talecris in Select Plasma Product Markets in terms of Revenues (includes corresponding Graph/Chart).....II-11
Competitive Landscape across Blood Banking, Blood Derived Products and Plasma
  Production.....II-11
Table 10: Leading Players in the Global Blood Screening Market (2011) (includes corresponding Graph/Chart).....II-11
1$350
   Table 11: Global Blood Derivatives Production (2011): Percentage Share Breakdown of Leading Players - Baxter, CSL, Grifols (incl. Talecris), Octapharma, Novo Nordisk Bayer, Pfizer, Non-Profit Organizations, and Others (includes corresponding Graph/Chart).....II-12

Table 12: Global Blood Plasma Manufacturing Market (2011): Percentage Share Breakdown by Leading Players - Baxter, CSL, Grifols (incl. Talecris), Pfizer, Novo Nordisk and Others (includes corresponding Graph/Chart).....II-12
Withdrawal of Octapharma’s IVIG Proves Advantageous to Competitors.....II-12
2$350
   Key Trends in Blood Banking/Pre-Transfusion Diagnostics.....II-14
Demand Exceeds Supply: Self-Sufficiency is the New Mantra.....II-14
PrIME: An Innovative High-Yield Process to Address Supply Dearth.....II-14
Present State of Plasma Fractionating Industry.....II-14
1$100
   Plasma Fractionation Industry Concentrated in Developed Countries.....II-15
PrIME Tackles the Issue of Currently Unprocessable Plasma.....II-15
New Infections – A Continuous Threat.....II-15
1$100
   Safety and Availability: The Core Issues.....II-16
Decontamination: A Viable Process.....II-16
New Processes for Safer Blood Supply.....II-16
1$100
   Diagnostic Innovative Procedures Help Blood Conservation.....II-17
Autologous Transfusion Strapping up for High Growth.....II-17
Enzyme Converted Cells Set to Rule the Industry.....II-17
Blood Unavailability: Substitutes to the Rescue.....II-17
1$100
   Transfusions: Hospitals Making Way for Others.....II-18
Computer Identification Helps Patients.....II-18
SARS: A Case of Mistaken Identity?.....II-18
Pooling: Economical HIV Testing.....II-18
1$100
   Private Cord Blood Banking: Flying High Despite Opposition.....II-19
Automation of Blood Banking – Nearing the Efficiency Frontier?.....II-19
Automated Instrumentation Taking the Front Seat.....II-19
1$100
   Table 13: World Market for Blood Bank Technology (2011): Percentage Breakdown of Revenues by Segment - Manual Blood Bag Systems, Automated Systems, Component Lab, Commercial Plasma, Blood Salvage, and Pathogen Inactivation (includes corresponding Graph/Chart).....II-20
Plasma Market: Automation Making Inroads.....II-20
The RBC Market – Slow to Catch Up.....II-20
Automation of Testing – Yet to Mature.....II-20
1$350
   Automation to Suffice Shortage Problems.....II-21
How Near to the Efficiency Frontier?.....II-21
1$100
   Blood Banking and Blood Products Industry.....II-22
Blood Components and Plasma Products.....II-22
Equipment, Blood Tests and Consumables.....II-22
Automated Analyzers for Blood Analysis.....II-22
Blood Tests.....II-22
1$100
   Consumables.....II-23
Blood Collection Equipment.....II-23
Blood Collection Monitors.....II-23
Blood Donor Couches.....II-23
Blood Processing Equipment.....II-23
Blood Bank Centrifuges.....II-23
Plasma Thawing.....II-23
1$100
   Blood Cell Separators.....II-24
Blood Storage Equipment.....II-24
Blood Bags.....II-24
Platelet Agitators.....II-24
Blood Bank Refrigerators.....II-24
Blood – A Primer.....II-24
Ionic Structure.....II-24
1$100
   Blood Components and their Applications.....II-251$100
   Blood Constituents.....II-26
Plasma.....II-26
Red Blood Cells (RBC).....II-26
1$100
   Blood Count.....II-27
Platelets.....II-27
White Blood Cells (WBC).....II-27
1$100
   Derivative Products of Blood or Plasma Fractions.....II-28
Plasma Protein and Fractionation.....II-28
Plasma Fractionation: Origins and Development.....II-28
1$100
   Table 14: Plasma Fractionation Processes: Comparison of Cohn IVIG and PrIME IVIG Based on Specific Characteristics.....II-29
The Need.....II-29
Fresh Frozen Plasma.....II-29
Other Plasma Fractions.....II-29
1$350
   Albumin Fractions.....II-30
Albumin Usage Rising in Profile, Wastage Worries Run Deep.....II-30
Immunoglobulins.....II-30
Immunoglobulin Products Available in the Market (2012).....II-30
1$100
   Table 15: Leading Countries in IVIg Usage Rates in Grams per 1000 Population (includes corresponding Graph/Chart).....II-31
Hyper-Immune Immunoglobulin.....II-31
Factor VIII.....II-31
Factor IX and Factor IX Complex.....II-31
Fibrin/Thrombin.....II-31
1$350
   Consumption of Blood Based on Type of Surgery/Accident (In Units).....II-32
Table 16: World Market for Plasma Derivatives (2011): Percentage Breakdown of Revenues by Product Type - IVIG, Albumin, vWFactor & pdFVIII, Hyperimmunes, A1PI, Poly IG and Others (includes corresponding Graph/Chart).....II-32
Recombinant Products.....II-32
1$350
   Development Pipeline of Select rFVIII Products for Hemophilia A Therapy: Breakdown by
   Product Name, Developing Company, State of Development and Expected Market
    Launch.....II-33
Table 17: Global Market for Recombinant Hemophilia Therapy (2011): Percentage Share Breakdown for Leading Players (includes corresponding Graph/Chart).....II-33
Therapeutic Uses of Plasma Products.....II-33
Albumin Products.....II-33
1$350
   Immunoglobulins.....II-34
Intravenous Immunoglobulin (IVIg).....II-34
Normal Immunoglobulin (IMIg).....II-34
CMV Immunoglobulin.....II-34
Hepatitis B Immunoglobulin.....II-34
Rh (D) Immunoglobulin.....II-34
Tetanus Immunoglobulin IM.....II-34
1$100
   Zoster Immunoglobulin.....II-35
Table 18: Global Market for Immunoglobulins (IG) (2012): Percentage Share Breakdown of Leading Products (includes corresponding Graph/Chart).....II-35
Plasma Derived Coagulant Products.....II-35
Biostate®.....II-35
Ceprotin®.....II-35
Factor VII Concentrate.....II-35
Factor XI Concentrates.....II-35
1$350
   Feiba VH® Inhibitor Treatment.....II-36
Fibrogammin P®.....II-36
Monofix®-VF.....II-36
ProthrombinexTM-HT.....II-36
Thrombotrol®-VF.....II-36
1$100
   Banking the Natural Blood Resources.....II-37
Blood Banks.....II-37
Blood Banking.....II-37
Blood Transfusion.....II-37
Role of Blood Banks.....II-37
Blood Donor: The Epicenter of the Process.....II-37
1$100
   Eligibility Criteria for the Donor.....II-38
The Basics of Blood Donation – Myths Exploded & Other Facts.....II-38
1$100
   Table 19: Active Donors of Whole Blood and Apheresis per 1,000 of Population by Country/ Agency (includes corresponding Graph/Chart).....II-39

Table 20: Percentage Breakdown of Apheresis and Whole Blood Donations by Country (includes corresponding Graph/Chart).....II-39
1$350
   Collection Methods.....II-40
Blood Donation: The Process.....II-40
Types of Blood Donation.....II-40
Directed Blood Donations.....II-40
Autologous Blood Donation.....II-40
Alternative Usage of Patient’s Own Blood.....II-40
General Blood Donation.....II-40
1$100
   Hemodilution.....II-41
Wound Drainage.....II-41
Cell Saver.....II-41
The Method.....II-41
Blood Salvaging.....II-41
Blood Collection Centers.....II-41
1$100
   Blood Collection Management System.....II-42
A Historical Retrospective.....II-42
Blood Collection Centers.....II-42
Types of Blood Collection Centers.....II-42
Cord Blood Banks.....II-42
Profit Collection Centers.....II-42
1$100
   Military Blood Banks.....II-43
Hospital Blood Banks.....II-43
Community Blood Banks.....II-43
Non-Profit Collection Centers.....II-43
Blood Processing.....II-43
1$100
   Blood Typing.....II-44
Rh Blood Group System.....II-44
1$100
   ABO Blood Group System.....II-45
Blood Types and their Compatibility.....II-45
Table 21: Occurrence of Blood Groups Worldwide (In %) (includes corresponding Graph/Chart).....II-45
1$350
   Blood Test.....II-46
Blood Culture.....II-46
The Costs.....II-46
History of Blood Banking.....II-46
3$300
   Blood Transfusion: A Backdrop.....II-49
Massive Transfusion.....II-49
Complications and Risks Due to Transfusion.....II-49
1$100
   Circulatory Overload.....II-50
Graft Versus Host Disease (GVHD).....II-50
Hemolytic Transfusion Reactions.....II-50
Iron Overload.....II-50
Bacterial Contamination.....II-50
Thrombophlebitis.....II-50
Allergic Reactions.....II-50
1$100
   Air Embolism.....II-51
Hyperkalaemia.....II-51
Changing Role of Blood Banking Technology.....II-51
1$100
   Cross Matching.....II-52
Blood Donor/Recipient Screening.....II-52
Blood Typing.....II-52
Leukoreduction.....II-52
1$100
   Leukocyte Reduction Specification Standards/Filters.....II-53
Coombs Test.....II-53
1$100
   Bloodless Surgery.....II-54
Therapeutic Apheresis.....II-54
Plasmapheresis.....II-54
Plateletpheresis.....II-54
1$100
   Leukapheresis.....II-55
Volume Expanders.....II-55
Colloids.....II-55
Albumin.....II-55
Dextrans.....II-55
Hydroxyethyl Starch.....II-55
Crystalloids.....II-55
1$100
   Blood Growth Factor Therapies – Newer Alternatives to Transfusion.....II-561$100
   Blood Substitutes Under Development by Manufacturers.....II-571$100
   Synthetic Blood Manufacturers/Developers.....II-58
Alliance Pharmaceuticals Corp. (US).....II-58
Biopure Corporation (US).....II-58
1$100
   Enzon Pharmaceuticals (US).....II-59
Hemosol Inc. (Canada).....II-59
Northfield Laboratories Inc. (US).....II-59
Synthetic Blood International, Inc. (US).....II-59
1$100
   America's Blood Centers Launches Management System for Blood Products.....II-60
Biomatrica Introduces DNAstable® Blood and DNAgard® Blood for Whole Blood Stabilization
  at Room Temperature.....II-60
Bio-Rad Launches Fully-Automated IH 1000 Blood Screening System.....II-60
1$100
   Fenwal Receives US FDA Clearance for Fenwal Amicus® Separator System.....II-61
BD Unveils BD Microtainer® MAP Microtube.....II-61
1$100
   Pall Releases Advanced Blood Filter.....II-62
CaridianBCT Rolls Out RBCX Protocol.....II-62
1$100
   ITL Launches TEGO™ Animal Blood Collection Kit.....II-63
Fenwal to Launch Modified ALYX Kit.....II-63
QIAGEN Launches New QIAsafe DNA Blood Products.....II-63
1$100
   Gambro Introduces New Prismaflex eXeed™ System.....II-64
AnaSpec Unveils ‘SensoLyte® Rh110 Plasmin Activity Assay Kit.....II-64
1$100
   Typenex® Medical Rolls Out New Barcode Blood Band.....II-65
Olympus Introduces Hemoglobin A1c APT Reagent for Chemistry Analyzer System.....II-65
BD Diagnostics Launches BD BACTEC™ FX Blood Culture System.....II-65
1$100
   Beckman Coulter Launches UniCel DxH 800 Coulter® Cellular Analysis System.....II-661$100
   Quotient Receives FDA Approval for ALBAcyte Reagent RBC Products.....II-67
EMIT Wins FDA Market Approval for Hypotherm X HX100 Device.....II-67
MedPro Blood Collection Safety Products Obtain CE Mark.....II-67
1$100
   Huaren Pharmaceutical GI and PD Solutions Obtain SFDA Approval.....II-68
Cerus INTERCEPT Blood System Obtains Approval from Swissmedic.....II-68
Abbott Obtains BLA Clearance from FDA for ABBOTT PRISM Chagas Test.....II-68
1$100
   CaridianBCT Obtains FDA Approval for New 6.0 Trima Accel® Automated Blood Collection
  System.....II-69
FDA Grants 510(K) Clearance for Expanded Use of Haemonetics.....II-69
Fenwal Secures FDA Approval for New Platelet Additive Solution.....II-69
1$100
   BD Diagnostics Bags FDA Approval for BD Vacutainer® Rapid Serum Tube.....II-70
Abbott Obtains FDA Approval for Abbott Prism HIV O Plus Test.....II-70
2$200
   Cerus Receives CE Mark Approval for the INTERCEPT Blood System for Platelets.....II-72
Haemonetics Wins FDA Approval for the ACP 215 System.....II-72
Biomerieux’ Polycarbonate BacT/ALERT Receives US FDA Clearance.....II-72
1$100
   Pall’s eBDS Receives Green Signal from FDA.....II-73
CardioPAT™ Surgical Blood Salvage System.....II-73
PCS® 2 – Set to Enhance Plasma Quality.....II-73
Dade Behring’s D-Dimer Assay Strapping up for Roll Out.....II-73
1$100
   Hologic to Take Over Gen-Probe.....II-74
ProMetic Obtains New Purchase under Octapharma Agreement.....II-74
Grifols Takes Over Talecris.....II-74
1$100
   IVD Acquisition Acquires Immucor.....II-75
Nordson Takes Over Value Plastics.....II-75
American Red Cross Takes Over RBC Collection Assets of HemaCare.....II-75
1$100
   Terumo Acquires CaridianBCT.....II-76
Bioniche to Take Over Plasvacc.....II-76
Logic Management Consulting to Take Over Guiyang Dalin Biologic Technologies.....II-76
Humanwell Healthcare Acquires Further Stake in Zhongyuan Ruide Bio.....II-76
1$100
   Red Cross and Mitsubishi Tanabe to Combine Plasma Fractionation Business.....II-77
Fenwal Signs Definitive Agreement with Golden Meditech to Set Up JV.....II-77
Fenwal and Biolog-id Enter into Marketing Agreement.....II-77
1$100
   GE Healthcare and Neste Jacobs Enter into Partnership.....II-78
Cerus Enters into Supply Agreement with Etablissement Francais du Sang.....II-78
Transfusion Management Services and Vedant Enter into Partnership.....II-78
1$100
   Global Healing Collaborates with Partners in Health.....II-79
ProMetic Expands Strategic Partnership with WIBP.....II-79
1$100
   Amunix Partners with Biogen Idec.....II-80
Fenwal and GenesisBPS Ink Agreement for Blood-Specialty Products.....II-80
Remi Enters into Collaboration with Barkey for Indian Market.....II-80
Huaren Pharma to Set Up R&D Center for Blood Purification.....II-80
1$100
   China Biologic to Commence Commercial Collection of Plasma at Ninyang.....II-81
Grifols to Construct Plasma Fractionation Plant.....II-81
HLL Lifecare Inaugurates Second Blood Bag Plant in India.....II-81
1$100
   Pall Inks Distribution Agreement with ASI.....II-82
Cerus Inks Deal with Swiss Red Cross for Deploying INTERCEPT Blood System.....II-82
PT Bio Farma to Construct New Albumin Plant in Indonesia.....II-82
NACO to Establish Plasma Fractionation Facility in Chennai.....II-82
1$100
   Improve Medical Instruments to Establish Subsidiary in Beijing.....II-83
China Biologic Products Obtains License for Plasma Collection from Shandong Province
  Health Department.....II-83
Sorin Group Sells Two Non-Core Product Lines to Cytomedix.....II-83
Sigma to Lease QC Manager Software to New Orleans based Blood Center.....II-83
1$100
   CaridianBCT's PRT System Chosen by Polish Health Ministry.....II-84
Micronics Obtains FDA Approval to Market ABORhCard.....II-84
HemaCare Signs Two New Blood Service Contracts.....II-84
1$100
   Haemonetics Gains Rights to Alba’s Full Line of Blood Typing Reagents.....II-85
American Red Cross Inks 3-Year Deal with ITL.....II-85
Daxor’s Idant Labs Bags Blood Banking Contract from RMSB&G.....II-85
1$100
   Beckman Coulter Agrees to Distribute CellaVision Digital Morphology Products.....II-86
Haemonetics Takes Over Global Med.....II-86
Therapure Biopharma Inks Long Term Pact with LFB Biomedicaments.....II-86
1$100
   MRHC Obtains License for SafeTrace Tx Solution of Global Med.....II-87
Life Technologies to Acquire AcroMetrix.....II-87
Heska Enters into a Supply Agreement with Roche Diagnostics.....II-87
1$100
   BLOOD Bank of Alaska Obtains License for Mediware’s LifeTrak Technology.....II-88
Europe and the US Expand Blood Banking Agreement.....II-88
1$100
   Pfizer Acquires Wyeth.....II-89
Baxter Inaugurates New BLOOD Plasma Fractionation Facility in Vienna.....II-89
ProMetic Acquires Majority Shareholding in PRDT.....II-89
1$100
   China Biologic to Collaborate with IBT on Research & Development.....II-90
Gen-Probe to Establish Independent New Firm for Industrial Testing.....II-90
1$100
   Haemonetics Acquires SEBRA Blood Collection & Processing Unit.....II-911$100
   Beckman Coulter Acquires Lab Based Diagnostics Business of Olympus.....II-92
Golden Meditech and Fenwal to Establish a Blood Collection Joint Venture in
  China.....II-92
PRCS Inaugurates State-of-the-Art Blood Bank.....II-92
1$100
   CSL and Talecris Terminate Merger Agreement.....II-93
Immucor Inks 5-Year Deal with Alverno.....II-93
1$100
   Gen-Probe Acquires Tepnel and Renews Partnership with Novartis.....II-94
Haemonetics Takes Over Neoteric Technology.....II-94
1$100
   Haemonetics Acquires Altivation Software.....II-95
PacifiCord Sets Up Cord Blood Banking Facility in Irvine.....II-95
China Biologic Acquires 35% Stake in Xi`an Huitian Blood Products.....II-95
1$100
   Octapharma Plans to Set Up Fractionation Facility in Poland.....II-96
Therapure BioPharma Inks Development Services Deal with LFB Biotechnologies.....II-96
Biotest Acquires Blood Plasma Collection Center from Talecris.....II-96
Gen-Probe Expands and Extends Blood Screening Alliance with Novartis.....II-96
1$100
   Celestial Biologicals Collaborates with GE Healthcare for Indian Market.....II-971$100
   Leading Blood Banks.....II-98
AABB (US).....II-98
America’s Blood Centers (US).....II-98
American Red Cross (US).....II-98
1$100
   Canadian Blood Services (Canada).....II-99
Japan Red Cross Society (Japan).....II-99
National Blood Foundation (US).....II-99
1$100
   New York Blood Center (US).....II-100
Leading Players in Blood Bank Technology and Supplies.....II-100
Beckman Coulter, Inc. (US).....II-100
Becton, Dickinson and Company (US).....II-100
1$100
   BioMerieux SA (France).....II-101
CSL Behring LLC (US).....II-101
Daxor Corporation (US).....II-101
1$100
   Fenwal Inc. (US).....II-102
Gen-Probe, Inc. (US).....II-102
Haemonetics Corporation (US).....II-102
1$100
   Hemagen Diagnostics Inc. (US).....II-103
Immucor Inc. (US).....II-103
1$100
   Kawasumi Laboratories, Inc. (Japan).....II-104
Novartis Vaccines and Diagnostics, Inc (US).....II-104
1$100
   Terumo Corp. (Japan).....II-105
Terumo BCT Inc (US).....II-105
ThermoGenesis Corp. (US).....II-105
1$100
   Velico Medical, Inc. (US).....II-106
Leading Players in Plasma Fractionation.....II-106
Baxter International Inc. (US).....II-106
Beijing Tiantan Biological Products Co., Ltd (China).....II-106
Bharat Serums and Vaccines Ltd (India).....II-106
1$100
   Bio Products Laboratory Ltd (UK).....II-107
Biotest AG (Germany).....II-107
CSL Limited (Australia).....II-107
1$100
   Grifols, S.A (Spain).....II-108
Guizhou Taibang Biological Products Co., Ltd (China).....II-108
1$100
   Huanlan Biological Engineering Inc. (China).....II-109
Kedrion S.p.A. (Italy).....II-109
Laboratoire Français du Fractionnement et des Biotechnologies (France).....II-109
Octapharma AG (Switzerland).....II-109
1$100
   OMRIX Biopharmaceuticals Ltd (Israel).....II-110
Shanghai RAAS Blood Products Co., Ltd. (China).....II-110
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd (China).....II-110
Sanquin (The Netherlands).....II-110
1$100
   Table 22: World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1111$350
   Table 23: World Historic Review for Blood Banking and Blood Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1121$350
   Table 24: World 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....II-1131$350
   Blood Banking and Blood Products Market by Product Group/Segment.....II-114
Table 25: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-114
1$350
   Table 26: World Historic Review for Blood Components and Plasma Products by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1151$350
   Table 27: World 15-Year Perspective for Blood Components and Plasma Products by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....II-1161$350
   Table 28: World Recent Past, Current & Future Analysis for Blood Components and Plasma Products by Product Segment - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1171$350
   Table 29: World Historic Review for Blood Components and Plasma Products by Product Segment - Whole Blood & Cellular Components, and Plasma Fractions Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1181$350
   Table 30: World 15-Year Perspective for Blood Components and Plasma Products by Product Segment - Percentage Breakdown of Value Sales for Whole Blood & Cellular Components, and Plasma Fractions Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....II-1191$350
   Table 31: World Recent Past, Current & Future Analysis for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1201$350
   Table 32: World Historic Review for Whole Blood & Cellular Components by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1211$350
   Table 33: World 15-Year Perspective for Whole Blood & Cellular Components by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....II-1221$350
   Table 34: World Recent Past, Current & Future Analysis for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1231$350
   Table 35: World Historic Review for Plasma Fractions by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1241$350
   Table 36: World 15-Year Perspective for Plasma Fractions by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....II-1251$350
   Table 37: World Recent Past, Current & Future Analysis for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....II-1261$350
   Table 38: World Historic Review for Equipment, Blood Tests and Other Consumables by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....II-1271$350
   Table 39: World 15-Year Perspective for Equipment, Blood Tests and Other Consumables by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart).....II-1281$350
   A. Market Analysis.....III-1
Current and Future Analysis.....III-1
Table 40: Blood and Organ Banks in the US (2011): Percentage Share Breakdown of Revenues for Major Players - American Red Cross, Musculoskeletal Transplant Foundation Inc., Community Blood Center and Community Tissue Services and CSL Ltd. (includes corresponding Graph/Chart).....III-1
1$200
   Table 41: US Blood Bank Industry (2011): Percentage Share Breakdown by Major Blood Suppliers (includes corresponding Graph/Chart).....III-2
Market Trends.....III-2
Recession Impacts Blood Bank Reserves.....III-2
US Blood Collection & Supply Profile.....III-2
1$200
   Blood Group Distribution.....III-3
Table 42: US Market for Blood Banking and Blood Products: Percentage Break up of Blood Group by Rh Factor (includes corresponding Graph/Chart).....III-3
1$200
   Table 43: Percentage Break up of Rh Blood Types in the US by Racial Group (includes corresponding Graph/Chart).....III-4
Blood Donated and Transfused Every Year.....III-4
Males Form the Major Chunk of Donors.....III-4
Cost of Blood.....III-4
SARS Scares: Blood Banks Feel the Heat.....III-4
1$200
   Blood and Blood Preparations: A Review of Trade Statistics.....III-5
Table 44: US Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Imports by Country of Origin for Germany, UK, Canada, Switzerland, Belgium and Others (includes corresponding Graph/Chart).....III-5
1$200
   Table 45: US Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Exports by Destination for UK, Germany, Canada, Netherlands, Belgium and Others (includes corresponding Graph/Chart).....III-6

Table 46: US Market for Globulins (2011): Percentage Breakdown by Leading Players for Baxter, Grifols (incl. Talecris), CSL and Octapharma (includes corresponding Graph/Chart).....III-6
1$200
   US Blood Components and Plasma Market Analysis in Units.....III-7
Table 47: US Recent Past, Current & Future Analysis for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-7
1$200
   Table 48: US Historic Review for Blood Components and Plasma by Product Category - Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma Markets Independently Analyzed with Annual Consumption in Million Units for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-8

Table 49: US 15-Year Perspective for Blood Components and Plasma by Product Category - Percentage Breakdown of Volume Consumption for Red Blood Cells (RBCs), Platelets, and Fresh Frozen Plasma for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-8
1$200
   Regulations Control Plasma Collection Industry.....III-9
Product launch.....III-9
Strategic Corporate Developments.....III-9
4$300
   Key players.....III-138$600
   B. Market Analytics.....III-21
Table 50: US Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-21
1$200
   Table 51: US Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-221$200
   Table 52: US 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-231$200
   A. Market Analysis.....III-24
Current and Future Analysis.....III-24
Blood Facts.....III-24
Bleeding Disorders – A Major Threat.....III-24
'CSA-Z902-04' – A Comprehensive Voluntary Blood Safety Standard.....III-24
1$75
   Blood and Blood Preparations: Import & Export Scenario.....III-25
Table 53: Canadian Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Imports by Country of Origin for US, Switzerland, Germany, Netherlands, UK and Other Countries (includes corresponding Graph/Chart).....III-25
1$200
   Table 54: Canadian Blood and Blood Preparations Market (2010 & 2011): Percentage Breakdown of Value Exports by Destination for US, France, UK, Japan, Australia and Other Countries (includes corresponding Graph/Chart).....III-26
Strategic Corporate Development.....III-26
1$200
   Canadian Blood Services – the Major Blood Bank.....III-271$75
   B. Market Analytics.....III-28
Table 55: Canadian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-28
1$200
   Table 56: Canadian Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-291$200
   Table 57: Canadian 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-301$200
   A. Market Analysis.....III-31
Current and Future Analysis.....III-31
Japan Witnesses Surge in Imported Blood Products.....III-31
Growing Market for Fresh Frozen Plasma.....III-31
Growing Use of Imported Albumin Based Blood Products.....III-31
1$75
   The Goal of Self-Sufficiency.....III-321$75
   Strategic Corporate Development.....III-33
Key players.....III-33
2$150
   B. Market Analytics.....III-35
Table 58: Japanese Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-35
1$200
   Table 59: Japanese Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-361$200
   Table 60: Japanese 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-371$200
   A. Market Analysis.....III-38
Current and Future Analysis.....III-38
European Blood Banking and Blood Products Market at a Glance (All figures are 2012
  estimates & CAGR is for the period 2010-2018).....III-38
1$75
   Market Trends and Issues.....III-39
Legislations on Payment for Donation Restrict Donors.....III-39
Government’s Check on Healthcare Costs Pressurizes BCT Manufacturers.....III-39
Purchasing System Witnesses Modifications.....III-39
EU Nations Marching Towards Self-Sufficiency in Blood and Blood Products.....III-39
Blood Banking Devices Market.....III-39
1$75
   Table 61: European Recent Past, Current & Future Analysis for Blood Banking Devices - Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-401$200
   Table 62: European Historic Review for Blood Banking Devices - Manual Blood Collection, Apheresis, and Autologous Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-411$200
   Table 63: European 15-Year Perspective for Blood Banking Devices - Percentage Breakdown of Value Sales for Manual Blood Collection, Apheresis, and Autologous Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-42

Table 64: European Blood Banking Devices Market (2012): Percentage Breakdown of Value Sales by Geographic Region for France, Germany, Italy, UK, Spain and Rest of Europe (includes corresponding Graph/Chart).....III-42
1$200
   A Snapshot of Health Care Systems Across Select EU Countries.....III-43
France.....III-43
Germany.....III-43
Italy.....III-43
The UK.....III-43
Spain.....III-43
1$75
   B. Market Analytics.....III-44
Table 65: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-44
1$200
   Table 66: European Historic Review for Blood Banking and Blood Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-451$200
   Table 67: European 15-Year Perspective for Blood Banking and Blood Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-461$200
   Table 68: European Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-471$200
   Table 69: European Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-481$200
   Table 70: European 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-491$200
   A. Market Analysis.....III-50
Current and Future Analysis.....III-50
Strategic Corporate Development.....III-50
Key players.....III-50
2$150
   B. Market Analytics.....III-52
Table 71: French Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-52
1$200
   Table 72: French Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-531$200
   Table 73: French 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-541$200
   A. Market Analysis.....III-55
Current and Future Analysis.....III-55
Biotest AG – A Key Player.....III-55
1$75
   B. Market Analytics.....III-56
Table 74: German Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-56
1$200
   Table 75: German Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-571$200
   Table 76: German 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-581$200
   A. Market Analysis.....III-59
Current and Future Analysis.....III-59
Kedrion S.p.A. – A Key Player.....III-59
1$75
   B. Market Analytics.....III-60
Table 77: Italian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-60
1$200
   Table 78: Italian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-611$200
   Table 79: Italian 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-621$200
   A. Market Analysis.....III-63
Current and Future Analysis.....III-63
Blood Requirements.....III-63
Bio Products Laboratory Ltd – A Key Player.....III-63
1$75
   B. Market Analytics.....III-64
Table 80: The UK Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-64
1$200
   Table 81: The UK Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-651$200
   Table 82: The UK 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-661$200
   A. Market Analysis.....III-67
Current and Future Analysis.....III-67
Strategic Corporate Development.....III-67
Grifols, S.A – A Key Player.....III-67
1$75
   B. Market Analytics.....III-68
Table 83: Spanish Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-68
1$200
   Table 84: Spanish Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-691$200
   Table 85: Spanish 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-701$200
   A. Market Analysis.....III-71
Current and Future Analysis.....III-71
1$75
   B. Market Analytics.....III-72
Table 86: Russian Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-72
1$200
   Table 87: Russian Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-731$200
   Table 88: Russian 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-741$200
   A. Market Analysis.....III-75
Current and Future Analysis.....III-75
Denmark – High Participation and Consumption of Blood.....III-75
Key players.....III-75
1$75
   B. Market Analytics.....III-76
Table 89: Rest of Europe Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-76
1$200
   Table 90: Rest of Europe Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-771$200
   Table 91: Rest of Europe 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-781$200
   A. Market Analysis.....III-79
Current and Future Analysis.....III-79
Overview of Select Regional Markets.....III-79
ASEAN – Striding Towards Standardization of Blood Supply.....III-79
China – A Key Market.....III-79
Blood Collection Industry: A Snapshot of the Past.....III-79
1$75
   Blood Products Industry – An Overview.....III-80
Performance Review.....III-80
1$75
   Chinese Blood Products Industry Poised for Expansion.....III-81
Table 92: Blood Products Industry in China (2009 & 2011): Percentage Breakdown by Product Type for Albumin, IVIG, Coagulation Factor and Others (includes corresponding Graph/Chart).....III-81
Volume Declines but Revenues Shoot Up in Chinese Blood Products Market.....III-81
1$200
   Government Wakes Up to Realities.....III-82
Table 93: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Group by Type - A, B, O, and AB (includes corresponding Graph/Chart).....III-82

Table 94: Chinese Market for Blood Banking and Blood Products: Percentage Breakdown of Blood Donor by Gender - Male and Female (includes corresponding Graph/Chart).....III-82
1$200
   Table 95: Chinese Blood Banking and Blood Products Market: Percentage Breakdown of Blood Donor by Age Group - 16-20, 21-30, 31-40, 41-50, 51-60, and 61-70 (includes corresponding Graph/Chart).....III-83
Albumin Market in China Gains Favor of both Global and Local Players.....III-83
Table 96: Albumin Market in China (2011): Percentage Share Breakdown by Leading Players - CSL, Octapharma, Baxter, Grifols, CBPO, Hualan Biological, Chengdu Rongsheng, Sichuan Yuanda, Green Cross and Others (includes corresponding Graph/Chart).....III-83
1$200
   India.....III-84
Blood Banking Equipment Market on the Rise.....III-84
Tube Sealers and Blood Bags Dominate the Market.....III-84
Recent Trends in the Market.....III-84
1$75
   Indian Blood Banking Market Witnesses Major Transformations.....III-85
Market Growth – Influencing Factors.....III-85
Increased Awareness Drives Voluntary Blood Donations in India.....III-85
1$75
   Competitive Scenario.....III-861$75
   Australia.....III-87
National Blood Supply: An Overview.....III-87
Role of National Blood Authority.....III-87
Maintenance Expenditure on the Rise.....III-87
Indonesia.....III-87
1$75
   Strategic Corporate Developments.....III-882$150
   Key players.....III-903$225
   B. Market Analytics.....III-93
Table 97: Asia-Pacific Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-93
1$200
   Table 98: Asia-Pacific Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-941$200
   Table 99: Asia-Pacific 15-Year Perspective for Blood Banking and Blood Products by Product Group/ Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-951$200
   A. Market Analysis.....III-96
Current and Future Analysis.....III-96
Strategic Corporate Development.....III-96
1$75
   B. Market Analytics.....III-97
Table 100: Latin American Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-97
1$200
   Table 101: Latin American Historic Review for Blood Banking and Blood Products by Product Group/ Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-981$200
   Table 102: Latin American 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-991$200
   A. Market Analysis.....III-100
Current and Future Analysis.....III-100
OMRIX Biopharmaceuticals Ltd (Israel) – A Key player.....III-100
1$75
   B. Market Analytics.....III-101
Table 103: Rest of World Recent Past, Current & Future Analysis for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2010 through 2018 (includes corresponding Graph/Chart).....III-101
1$200
   Table 104: Rest of World Historic Review for Blood Banking and Blood Products by Product Group/Segment - Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2004 through 2009 (includes corresponding Graph/Chart).....III-1021$200
   Table 105: Rest of World 15-Year Perspective for Blood Banking and Blood Products by Product Group/Segment - Percentage Breakdown of Value Sales for Blood Components and Plasma Products (Whole Blood & Cellular Components, and Plasma Fractions); and Equipment, Blood Tests and Other Consumables Markets for Years 2004, 2011 & 2018 (includes corresponding Graph/Chart).....III-1031$200
  
Total Companies Profiled: 232 (including Divisions/Subsidiaries - 338)

Region/Country Players

The United States 145 Canada 15 Japan 11 Europe 101 France 11 Germany 26 The United Kingdom 17 Italy 6 Spain 4 Rest of Europe 37 Asia-Pacific (Excluding Japan) 54 Latin America 6 Africa 3 Middle-East 3
Click here to request a full table of contents and more details on this project.